Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2001-6-6
pubmed:abstractText
Treatment of hypertension in patients with chronic renal failure has been shown to postpone the decline in renal function. Treatment with an ACE inhibitor has been shown to be superior to conventional antihypertensive treatment, but it is not known how an ACE inhibitor compares to treatment with a calcium channel blocker or to treatment with a combination of these drugs. The aim of the study was to evaluate the rate of decline in GFR in patients with chronic renal failure and hypertension treated with isradipine and spirapril as monotherapy and in combination.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0301-0430
pubmed:author
pubmed:issnType
Print
pubmed:volume
55
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
375-83
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:11393383-Adolescent, pubmed-meshheading:11393383-Adult, pubmed-meshheading:11393383-Aged, pubmed-meshheading:11393383-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:11393383-Blood Pressure, pubmed-meshheading:11393383-Calcium Channel Blockers, pubmed-meshheading:11393383-Disease Progression, pubmed-meshheading:11393383-Double-Blind Method, pubmed-meshheading:11393383-Drug Therapy, Combination, pubmed-meshheading:11393383-Enalapril, pubmed-meshheading:11393383-Female, pubmed-meshheading:11393383-Glomerular Filtration Rate, pubmed-meshheading:11393383-Humans, pubmed-meshheading:11393383-Hypertension, Renal, pubmed-meshheading:11393383-Isradipine, pubmed-meshheading:11393383-Kidney, pubmed-meshheading:11393383-Kidney Failure, Chronic, pubmed-meshheading:11393383-Male, pubmed-meshheading:11393383-Middle Aged, pubmed-meshheading:11393383-Prospective Studies, pubmed-meshheading:11393383-Renal Plasma Flow, Effective
pubmed:year
2001
pubmed:articleTitle
A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
pubmed:affiliation
Department of Nephrology, Hvidovre Hospital, Denmark. JPetersen@dadl.net
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't